Global and Japan Metabolomics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Metabolomics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Introduction
  • 1.2.3 Separation Techniques
  • 1.2.4 Detection Techniques
• 1.3 Market by Application
  • 1.3.1 Global Metabolomics Market Share by Application: 2020 VS 2026
  • 1.3.2 Introduction
  • 1.3.3 Drug Assessment
  • 1.3.4 Biomarker Discovery
  • 1.3.5 Nutrigenomics
  • 1.3.6 Clinical toxicology
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Metabolomics Market Perspective (2015-2026)
• 2.2 Global Metabolomics Growth Trends by Regions
  • 2.2.1 Metabolomics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Metabolomics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Metabolomics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Metabolomics Players by Market Size
  • 3.1.1 Global Top Metabolomics Players by Revenue (2015-2020)
  • 3.1.2 Global Metabolomics Revenue Market Share by Players (2015-2020)
• 3.2 Global Metabolomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Metabolomics Revenue
• 3.4 Global Metabolomics Market Concentration Ratio
  • 3.4.1 Global Metabolomics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Metabolomics Revenue in 2019
• 3.5 Key Players Metabolomics Area Served
• 3.6 Key Players Metabolomics Product Solution and Service
• 3.7 Date of Enter into Metabolomics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Metabolomics Breakdown Data by Type (2015-2026)

• 4.1 Global Metabolomics Historic Market Size by Type (2015-2020)
• 4.2 Global Metabolomics Forecasted Market Size by Type (2021-2026)

5 Metabolomics Breakdown Data by Application (2015-2026)

• 5.1 Global Metabolomics Historic Market Size by Application (2015-2020)
• 5.2 Global Metabolomics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Metabolomics Market Size (2015-2026)
• 6.2 North America Metabolomics Market Size by Type (2015-2020)
• 6.3 North America Metabolomics Market Size by Application (2015-2020)
• 6.4 North America Metabolomics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Metabolomics Market Size (2015-2026)
• 7.2 Europe Metabolomics Market Size by Type (2015-2020)
• 7.3 Europe Metabolomics Market Size by Application (2015-2020)
• 7.4 Europe Metabolomics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Metabolomics Market Size (2015-2026)
• 8.2 China Metabolomics Market Size by Type (2015-2020)
• 8.3 China Metabolomics Market Size by Application (2015-2020)
• 8.4 China Metabolomics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Metabolomics Market Size (2015-2026)
• 9.2 Japan Metabolomics Market Size by Type (2015-2020)
• 9.3 Japan Metabolomics Market Size by Application (2015-2020)
• 9.4 Japan Metabolomics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Metabolomics Market Size (2015-2026)
• 10.2 Southeast Asia Metabolomics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Metabolomics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Metabolomics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Thermo Fisher Scientific, Inc.
  • 11.1.1 Thermo Fisher Scientific, Inc. Company Details
  • 11.1.2 Thermo Fisher Scientific, Inc. Business Overview
  • 11.1.3 Thermo Fisher Scientific, Inc. Metabolomics Introduction
  • 11.1.4 Thermo Fisher Scientific, Inc. Revenue in Metabolomics Business (2015-2020))
  • 11.1.5 Thermo Fisher Scientific, Inc. Recent Development
• 11.2 Agilent Technologies, Inc.
  • 11.2.1 Agilent Technologies, Inc. Company Details
  • 11.2.2 Agilent Technologies, Inc. Business Overview
  • 11.2.3 Agilent Technologies, Inc. Metabolomics Introduction
  • 11.2.4 Agilent Technologies, Inc. Revenue in Metabolomics Business (2015-2020)
  • 11.2.5 Agilent Technologies, Inc. Recent Development
• 11.3 Biocrates Life Sciences AG
  • 11.3.1 Biocrates Life Sciences AG Company Details
  • 11.3.2 Biocrates Life Sciences AG Business Overview
  • 11.3.3 Biocrates Life Sciences AG Metabolomics Introduction
  • 11.3.4 Biocrates Life Sciences AG Revenue in Metabolomics Business (2015-2020)
  • 11.3.5 Biocrates Life Sciences AG Recent Development
• 11.4 Shimadzu Corporation
  • 11.4.1 Shimadzu Corporation Company Details
  • 11.4.2 Shimadzu Corporation Business Overview
  • 11.4.3 Shimadzu Corporation Metabolomics Introduction
  • 11.4.4 Shimadzu Corporation Revenue in Metabolomics Business (2015-2020)
  • 11.4.5 Shimadzu Corporation Recent Development
• 11.5 Waters Corporation
  • 11.5.1 Waters Corporation Company Details
  • 11.5.2 Waters Corporation Business Overview
  • 11.5.3 Waters Corporation Metabolomics Introduction
  • 11.5.4 Waters Corporation Revenue in Metabolomics Business (2015-2020)
  • 11.5.5 Waters Corporation Recent Development
• 11.6 Human Metabolome Technologies, Inc.
  • 11.6.1 Human Metabolome Technologies, Inc. Company Details
  • 11.6.2 Human Metabolome Technologies, Inc. Business Overview
  • 11.6.3 Human Metabolome Technologies, Inc. Metabolomics Introduction
  • 11.6.4 Human Metabolome Technologies, Inc. Revenue in Metabolomics Business (2015-2020)
  • 11.6.5 Human Metabolome Technologies, Inc. Recent Development
• 11.7 LECO Corporation
  • 11.7.1 LECO Corporation Company Details
  • 11.7.2 LECO Corporation Business Overview
  • 11.7.3 LECO Corporation Metabolomics Introduction
  • 11.7.4 LECO Corporation Revenue in Metabolomics Business (2015-2020)
  • 11.7.5 LECO Corporation Recent Development
• 11.8 Metabolon, Inc.
  • 11.8.1 Metabolon, Inc. Company Details
  • 11.8.2 Metabolon, Inc. Business Overview
  • 11.8.3 Metabolon, Inc. Metabolomics Introduction
  • 11.8.4 Metabolon, Inc. Revenue in Metabolomics Business (2015-2020)
  • 11.8.5 Metabolon, Inc. Recent Development
• 11.9 Bio-Rad Laboratories, Inc.
  • 11.9.1 Bio-Rad Laboratories, Inc. Company Details
  • 11.9.2 Bio-Rad Laboratories, Inc. Business Overview
  • 11.9.3 Bio-Rad Laboratories, Inc. Metabolomics Introduction
  • 11.9.4 Bio-Rad Laboratories, Inc. Revenue in Metabolomics Business (2015-2020)
  • 11.9.5 Bio-Rad Laboratories, Inc. Recent Development
• 11.10 Bruker Corporation
  • 11.10.1 Bruker Corporation Company Details
  • 11.10.2 Bruker Corporation Business Overview
  • 11.10.3 Bruker Corporation Metabolomics Introduction
  • 11.10.4 Bruker Corporation Revenue in Metabolomics Business (2015-2020)
  • 11.10.5 Bruker Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer